The Department of Molecular Medicine (MOMA) at Aarhus University Hospital is highly specialized and renowned within molecular diagnostics and cancer research for more than 20 years.
The department also plays a central role in the recently established Danish National Genome Center (NGC) and will house whole-genome sequencing.
MOMA houses state-of-the-art laboratory facilities, comprehensive cancer biobanks, an extensive next-generation sequencing facility, access to a large high-performance computing facility, and extensive genomics data infrastructure.
MOMA focuses on translational research in particular molecular understanding of cancer, and endocrine diseases. Personal medicine aims at better diagnosis, treatment and prevention of disease for patients and their families.
We conduct basic and clinical studies in cancer of the colon, bladder and prostate supported by bioinformatic groups at MOMA. Our research focuses on identifying molecular markers for early detection of cancer, response to chemotherapy, tumor aggressiveness and monitoring recurrence. MOMA and our collaborators have established comprehensive biobanks in bladder cancer (1994), colon cancer (1999) and prostate cancer (2002).
We offer molecular diagnostics of neoplasms and cancer, heart disease, endocrinology and metabolism as a national and international service to clinicians. We implemented NGS in clinical practice back in 2013, potentially increasing the diagnostic yield. We analyze small and large gene panels (targeted sequencing), exomes and whole genomes.
The laboratory is accredited by the international laboratory standard DS/EN ISO 15189:2013 for medical examination - genetics.
MOMA is part of the Aarhus Center for Genomics and Personalized Medicine and has access to the Genome.dk high performance computing (HPC) facility at Aarhus University.
The department collaborates with international cancer experts as well as experts at Danish universities, software companies and in the biotech industry.